Astrana Health, Inc. Stock Price, News & Analysis

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported a 40% revenue increase to $317.0 million for Q3 2022, but net income decreased to $26.0 million from $34.3 million year-over-year. For the nine months ending September 30, 2022, total revenue was $850.0 million, up 47%, yet net income fell to $51.6 million from $60.1 million. The company is raising its full-year 2022 guidance for revenue and net income due to growth and favorable membership mix. Recent acquisitions are expected to enhance membership significantly.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will release its financial results for the third quarter and nine months ending September 30, 2022, on November 3, 2022, after market close. A conference call to discuss these results is scheduled for November 4, 2022, at 5:30 a.m. PT/8:30 a.m. ET. Investors can access the call via dial-in or online webcast, with a slide presentation available on the Company’s website. ApolloMed is focused on value-based care through its technology-powered healthcare model, enabling providers to deliver efficient patient care.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced an agreement to acquire Valley Oaks Medical Group, encompassing nine primary care clinics in Las Vegas, Houston, and Fort Worth. This strategic acquisition will expand ApolloMed's operations into Nevada and Texas while enhancing its value-based care services for over 20,000 patients, including 6,000 Medicare members. The transaction, expected to close by Q4 2022, will be funded with cash on hand. Leaders from both companies expressed enthusiasm for the partnership, aiming to improve healthcare delivery in underserved communities.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced a definitive agreement to acquire All American Medical Group (AAMG) and For Your Benefit, Inc. (FYB) to enhance its value-based care services. This acquisition includes 100% of AAMG's and FYB's assets and is expected to close by Q1 2023, pending regulatory approval. The deal will integrate over 15,000 patients in the San Francisco area into ApolloMed's network, expanding its reach to over 30,000 members in Northern California and leveraging AAMG's community-focused services.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced its participation in two virtual investor conferences. The Bank of America Healthcare Innovation Forum is scheduled for September 29, 2022, followed by the Barclays Value Based Care Investor Conference on October 6, 2022. Management will engage in one-on-one meetings at both events. ApolloMed, a technology-powered healthcare management firm, specializes in value-based care, providing integrated platforms to enhance patient care. For further information, visit www.apollomed.net.

Apollo Medical Holdings, Inc. reported significant financial results for Q2 and the first half of 2022. Total revenue reached $269.7 million, up 54% year-over-year. However, net income slightly decreased to $11.4 million from $12.7 million in Q2 2021. Year-to-date revenue rose 52% to $533.0 million, with net income nearly unchanged at $25.7 million. The company maintains its full-year guidance, projecting revenue between $1,055.0 million and $1,085.0 million. Cash reserves stood at $234.2 million as of June 30, 2022.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) will release its financial results for the second quarter and first half of 2022 after the market close on August 4, 2022. A conference call to discuss the results will follow at 2 p.m. PT / 5 p.m. ET. ApolloMed is a technology-powered healthcare management company focused on value-based care, operating an integrated healthcare delivery platform to enhance quality and cost-effective care. The company is headquartered in Alhambra, California.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) announced that Co-CEO Brandon Sim will present at two key investor conferences in New York. The 2022 RBC Capital Markets Global Healthcare Conference is scheduled for May 18, 2022, at 11:35 a.m. PT. The UBS Global Healthcare Conference 2022 will take place on May 23, 2022, at 11 a.m. PT. Both presentations will be available via live webcast on the company’s website. ApolloMed focuses on value-based care and operates an integrated healthcare delivery platform.

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has appointed Chan Basho as Chief Strategy Officer and Interim Chief Financial Officer, following Eric Chin's departure for personal reasons. Basho, with 15 years of experience in healthcare strategy and finance, is expected to enhance the company's growth strategy and ensure operational discipline. The leadership transition aims to strengthen ApolloMed's mission to deliver cost-effective, high-quality healthcare. Chin will remain with the company as an executive advisor for a smooth transition.